The lab of Dr. Clodagh O’Shea has patented their work on such a system, using efficient modular construction of different viruses to be used as viral labels of circulating tumor cells in a patient’s blood sample.These viral reporters infect their target cell, allowing its malignant characteristics to be identified within 24 hours. This system is a powerful tool for identifying the right treatment for each individual patient and for clinical testing, to stratify patients. The result could even be accelerated development of personalized cancer therapeutics. Source: http://salkinnovations.flintbox.com/public/filedownload/6208/adenoviral-tumor-diagnostics.pdf
